SUMITOMO PHARMA AMERICA HOLDINGS

sumitomo-pharma-america-holdings-logo

Sumitomo Pharma America Holdings encourages and facilitates the discovery, development, and commercialization of medications to benefit patients. They are committed to developing solutions that go beyond medication, offering more comprehensive support with a primary focus on active ageing and mental health.

#SimilarOrganizations #People #Website #More

SUMITOMO PHARMA AMERICA HOLDINGS

Social Links:

Industry:
Health Diagnostics Medical Pharmaceutical

Founded:
2009-01-01

Address:
Marlborough, Massachusetts, United States

Country:
United States

Website Url:
http://www.us.sumitomo-pharma.com

Total Employee:
51+

Status:
Active

Contact:
+1 800 461 9330

Email Addresses:
info@us.sumitomo-pharma.com

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Font API Google Tag Manager Font Awesome HSTS Cloudflare JS CDN JS Amazon S3


Similar Organizations

amarin-pharma-logo

Amarin Pharma

Amarin Corporation is a pharmaceutical company develops and commercialize therapeutics to improve patient health.

assertio-logo

Assertio

Assertio is a pharmaceutical company focused on developing and commercializing products to treat pain and other.

eleison-pharmaceuticals-logo

Eleison Pharmaceuticals

Eleison Pharmaceuticals acquires, develops, and commercializes clinical stage drug candidates for "orphan" cancers.

emmaus-medical-japan-logo

Emmaus Medical Japan

Emmaus Medical Japan engages in the discovery, development, and commercialization of innovative treatments for rare diseases.

healthwright-technologies-logo

HealthWright Technologies

HealthWright Technologies is a healthcare service provider & pharmaceutical firm that provides healthcare technology & patient services.

jubilant-radiopharma-logo

Jubilant Radiopharma

Jubilant Radiopharma is a leader in the development, manufacturing, and commercialization of radiopharmaceuticals.

molecularmd-logo

MolecularMD

MolecularMD provides molecular diagnostics products and services to support clinical development and commercialization of cancer therapies.

roche-molecular-systems-logo

Roche Molecular Systems

Roche Molecular Systems, Inc., a molecular diagnostics company, develops and commercializes diagnostic and blood screening tests based on

stat-research-logo

STAT Research

STAT Research is a clinical research center provides medications, treatments, and health care services.

transtech-pharma-logo

TransTech Pharma

TransTech Pharma is engaged in the discovery, development, and commercialization of human therapeutics.

Current Employees Featured

steven-egge_image

Steven Egge
Steven Egge SVP and General Manager @ Sumitomo Pharma America Holdings
SVP and General Manager
2023-07-01

not_available_image

Shinichiro Katayanagi
Shinichiro Katayanagi Chair and Chief Executive Officer @ Sumitomo Pharma America Holdings
Chair and Chief Executive Officer
2020-04-01

Founder


not_available_image

Shinichiro Katayanagi

Official Site Inspections

http://www.us.sumitomo-pharma.com

  • Host name: ec2-44-199-155-249.compute-1.amazonaws.com
  • IP address: 44.199.155.249
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Sumitomo Pharma America Holdings"

Innovative Treatments, Science and Technology | Sumitomo …

Drug discovery, development, and commercialization must become faster and more efficient to address humanity’s pressing health needs. From advancing novel science to delivering …See details»

Organizational Chart - Sumitomo Pharma

Sumitomo Pharma's organizational chart. Related Contents. Sumitomo Pharma's DX. Sustainability. Research and DevelopmentSee details»

Sumitomo Pharma America Launches as New Combined …

CAMBRIDGE, Mass., July 10, 2023 /PRNewswire/ — Sumitomo Pharma America, Inc. (SMPA), as previously announced on April 3, 2023, is pleased to share it has successfully launched its …See details»

New Expanded Scale, Resources Capabilities - Sumitomo Pharma

Jul 11, 2023 website: https://www.us.sumitomo‐pharma.com. About Sumitomo Pharma America, Inc. Sumitomo Pharma America (SMPA) is focused on delivering therapeutic and scientific …See details»

Sumitomo Pharma Announces Organizational Realignment and …

Print(PDF/181KB) Oct. 30, 2024 Corporate Sumitomo Pharma Announces Organizational Realignment and Changes in Executive Officers and Other Key Positions . Sumitomo Pharma …See details»

Sumitomo Pharma America Promotes Kenton Stewart to Chief …

Sep 23, 2024 MARLBOROUGH, Mass., September 23, 2024 – Sumitomo Pharma America, Inc. (SMPA) today announced that Kenton Stewart, Senior Vice President, Head of Sales and …See details»

Sumitomo Pharma Subsidiary Companies in the U.S., Including …

Apr 3, 2023 Sumitomo Pharma Oncology, Inc. Sumitomo Pharma Oncology, Inc. is a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. As a global oncology organization with teams …See details»

Sumitomo Pharma America - Overview, News & Similar companies …

Oct 1, 2023 Sumitomo Pharma America contact info: Phone number: (508) 481-6700 Website: us.sumitomo-pharma.com What does Sumitomo Pharma America do? Sumitomo Pharma …See details»

Sumitomo Pharma America Launches as New …

CAMBRIDGE, Mass., July 10, 2023 /PRNewswire/ -- Sumitomo Pharma America, Inc. (SMPA), as previously announced on April 3, 2023, is pleased to share it has successfully launched its operations in ...See details»

Sumitomo Pharma America Inc. (Morrisville) | North …

Sumitomo Pharma America develops therapies in critical disease areas across psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapies.See details»

Sumitomo Pharma Co., Ltd.

Sumitomo Pharma – a company with global business platforms. Sumitomo Pharma has established strong business foundations in Japan, the United States, and Chinese mainland, …See details»

Sumitomo Pharma America Holdings - Crunchbase

Sumitomo Pharma America Holdings has experienced a decline in its financial performance, leading to significant layoffs. The company laid off 400 staffers in the US due to sliding …See details»

Sumitomo Pharma America, Inc. - amga.org

Join us March 26-29, 2025 at the Gaylord Texan in Grapevine TX. Learn More. Key Topics. Back. Key Topics. Key Topics Areas ... SMPA was formed through the consolidation of Sumitomo …See details»

Sumitomo Pharma tidies up 7 units into one combined US entity

Apr 3, 2023 After the consolidation, Sumitomo Pharma will still have a few loose units in the organization chart. The Japanese company has four holdings companies in the U.K. that have …See details»

Sumitomo Pharma Announces Organizational Realignment and …

Print(PDF/145KB) Jan. 17, 2025 Corporate Sumitomo Pharma Announces Organizational Realignment and Personnel Changes. Sumitomo Pharma Co., Ltd. (Head Office: Osaka, …See details»

Sumitomo Pharma America Launches as New Combined …

CAMBRIDGE, Mass., July 10, 2023 /PRNewswire/ -- Sumitomo Pharma America, Inc. (SMPA), as previously announced on April 3, 2023, is pleased to share it has successfully launched its …See details»

About Us - Sumitomo Pharma

Sumitomo Pharma's corporate information. About Us. For the betterment of healthcare and fuller lives of people worldwide, we will continue to contribute to the society as a whole, by creating …See details»

Sunovion - Wikipedia

On July 1, 2023, Sunovion Pharmaceuticals Inc. became part of Sumitomo Pharma America, Inc., [1] a biopharmaceutical company focused on delivering therapeutic and scientific …See details»

Business Units - Sumitomo Pharma

About Us; business; Business Units. The Sumitomo Pharma Group’s core business is its Pharmaceutical Business, but the Group is also active in other business areas including …See details»

Corporate Profile - Sumitomo Pharma

At Sumitomo Pharma, we are focusing our efforts on the research and development of innovative and useful pharmaceuticals as well as healthcare solutions, in the relentless pursuit of our …See details»

linkstock.net © 2022. All rights reserved